AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31854481 — intervention group
Group type: COMPARATOR
Intervention: Control: Year prior to intervention where parents were not responsible for booking consultations.
Number of subjects: 139
Study 31745107 — intervention group
Group type: EXPERIMENTAL
Intervention: IV DMT
Number of subjects: 13
Study 31745107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 28994705 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified anthocyanins (320 mg/day)
Number of subjects: 160
Study 28994705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 25450868 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of sclerosant through an occluding balloon catheter (OB technique)
Number of subjects: 90
Study 25450868 — intervention group
Group type: COMPARATOR
Intervention: Injection of sclerosant through a diagnostic catheter (free catheter technique)
Number of subjects: 90
Study 23553796 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy with immediate surgery (SRT)
Number of subjects: 657
Study 23553796 — intervention group
Group type: COMPARATOR
Intervention: Short-course radiotherapy with surgery delayed for 4-8 weeks (SRT-delay)
Number of subjects: 657
Study 23553796 — intervention group
Group type: COMPARATOR
Intervention: Long-course radiotherapy with surgery delayed for 4-8 weeks (LRT-delay)
Number of subjects: 657
Study 23553796 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative to preoperative leucocyte ratio (low ratio)
Number of subjects: 657
Study 23553796 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative to preoperative leucocyte ratio (intermediate ratio)
Number of subjects: 657
Study 23553796 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative to preoperative leucocyte ratio (high ratio)
Number of subjects: 657
Study 21692281 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with psychological interference (combined therapy group)
Number of subjects: 120
Study 21692281 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 120
Study 21692281 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 120
Study 21692281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy group (EA + psychotherapy)
Number of subjects: 120
Study 19453574 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius WB21 (2.01 x 10(9) CFU/day)
Number of subjects: 66
Study 19453574 — intervention group
Group type: COMPARATOR
Intervention: Placebo with xylitol
Number of subjects: 66
Study 16310718 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive multidisciplinary treatment program
Number of subjects: 208
Study 16310718 — intervention group
Group type: EXPERIMENTAL
Intervention: Light multidisciplinary treatment program
Number of subjects: 208
Study 16310718 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual initiated by a general practitioner
Number of subjects: 208
Study 15110919 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborns with parental atopy and elevated cord IgE (> or = 0.5 kU/l)
Number of subjects: 51
Study 15110919 — intervention group
Group type: COMPARATOR
Intervention: Newborns without parental atopy and normal cord IgE
Number of subjects: 51
Study 15110919 — intervention group
Group type: EXPERIMENTAL
Intervention: All newborns
Number of subjects: 51
Study 11142547 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR
Number of subjects: 0
Study 11142547 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 0
Study 11142547 — intervention group
Group type: COMPARATOR
Intervention: Attention-placebo control
Number of subjects: 0
Study 9311710 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral (10 mg/kg/day)
Number of subjects: 33
Study 9311710 — intervention group
Group type: COMPARATOR
Intervention: Sandimmune (10 mg/kg/day)
Number of subjects: 33
Study 8141713 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (SK) and subcutaneous heparin (n = 9796)
Number of subjects: 40845
Study 8141713 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (SK) and intravenous heparin (n = 10,377)
Number of subjects: 40845
Study 8141713 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (t‐PA) and intravenous heparin (n = 10,344)
Number of subjects: 40845
Study 8141713 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SK and t‐PA (n = 10,328)
Number of subjects: 40845
Study 3490744 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain chest radiographs showing widening of the mediastinum
Number of subjects: 72
Study 3490744 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain chest radiographs showing widening of the aortic knob
Number of subjects: 72
Study 3490744 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall accuracy of radiologists' predictions
Number of subjects: 72
Study 3490744 — intervention group
Group type: EXPERIMENTAL
Intervention: Interobserver agreement on radiographic features
Number of subjects: 72
Study 30021545 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving intervention provided by rehabilitation coordinators at primary health care centers.
Number of subjects: 0
Study 30021545 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual provided by rehabilitation coordinators at primary health care centers.
Number of subjects: 0
Study 30021545 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving intervention
Number of subjects: 0
Study 30021545 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 0
Study 27084867 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera gel along with physiotherapy
Number of subjects: 40
Study 27084867 — intervention group
Group type: COMPARATOR
Intervention: Antioxidant capsules along with physiotherapy
Number of subjects: 40
Study 24819103 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine-derived acellular dermal matrix reinforcement
Number of subjects: 113
Study 24819103 — intervention group
Group type: COMPARATOR
Intervention: Standard end-stoma construction without reinforcement
Number of subjects: 113
Study 22922507 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline heart rate 77-82 b.p.m.
Number of subjects: 20165
Study 22922507 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline heart rate >82 b.p.m.
Number of subjects: 20165
Study 22922507 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline heart rate 71-76 b.p.m.
Number of subjects: 20165
Study 22922507 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower heart rate across all groups
Number of subjects: 20165
Study 22922507 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline heart rate associated with cognitive decline
Number of subjects: 20165
Study 22922507 — intervention group
Group type: EXPERIMENTAL
Intervention: Low heart rate
Number of subjects: 20165
Study 22922507 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline heart rate
Number of subjects: 20165
Study 20020319 — intervention group
Group type: EXPERIMENTAL
Intervention: Autism 1-2-3 early intervention for 2 weeks targeting eye contact, gesture, and vocalization/words
Number of subjects: 17
Study 20020319 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 17
Study 18678836 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin plus docetaxel (AT)
Number of subjects: 2882
Study 18678836 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin plus cyclophosphamide (AC)
Number of subjects: 2882
Study 15946410 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU+FRUC (1.2 g/min glucose + 1.2 g/min fructose)
Number of subjects: 8
Study 15946410 — intervention group
Group type: COMPARATOR
Intervention: GLU (1.2 g/min glucose)
Number of subjects: 8
Study 12680333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrameatal application of low dosage alprostadil (PGE1) cream (300 mcg)
Number of subjects: 43
Study 10525926 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (1mg/kg/BW) starting on day one after operation
Number of subjects: 200
Study 10525926 — intervention group
Group type: COMPARATOR
Intervention: Control group (therapy only in case of occurrence of atrial fibrillation)
Number of subjects: 200
Study 10525926 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol group
Number of subjects: 200
Study 10525926 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 8693245 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 8693245 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and/or radiotherapy
Number of subjects: 0
Study 8693245 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 8693245 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 1846940 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon gamma (50 micrograms per square meter of body-surface area)
Number of subjects: 128
Study 1846940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 1846940 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon gamma
Number of subjects: 128
Study 6402129 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiography
Number of subjects: 959
Study 6402129 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid surgery
Number of subjects: 959
Study 31040096 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial-impregnated PICC (miconazole and rifampicin)
Number of subjects: 861
Study 31040096 — intervention group
Group type: COMPARATOR
Intervention: Standard PICC (non-antimicrobial-impregnated)
Number of subjects: 861
Study 31040096 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial-impregnated PICC
Number of subjects: 861
Study 31040096 — intervention group
Group type: COMPARATOR
Intervention: Standard PICC
Number of subjects: 861
Study 30084415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) and Daclatasvir (DAC) for 24 weeks
Number of subjects: 61
Study 26800444 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session group lyric analysis intervention
Number of subjects: 144
Study 26800444 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 144
Study 24191261 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCT1 system with metallic posts
Number of subjects: 100
Study 24191261 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital radiographs with metallic posts
Number of subjects: 100
Study 24191261 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCT2 system with metallic posts
Number of subjects: 100
Study 24191261 — intervention group
Group type: COMPARATOR
Intervention: Film radiographs without metallic posts
Number of subjects: 100
Study 24191261 — intervention group
Group type: COMPARATOR
Intervention: Digital radiographs without metallic posts
Number of subjects: 100
Study 24191261 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCT1 examination
Number of subjects: 100
Study 22128083 — intervention group
Group type: EXPERIMENTAL
Intervention: golimumab 50 mg
Number of subjects: 356
Study 22128083 — intervention group
Group type: EXPERIMENTAL
Intervention: golimumab 100 mg
Number of subjects: 356
Study 22128083 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 356
Study 20626055 — intervention group
Group type: EXPERIMENTAL
Intervention: External Qigong Treatment (EQT)
Number of subjects: 50
Study 20626055 — intervention group
Group type: COMPARATOR
Intervention: Equivalent Attention Time (EAT)
Number of subjects: 50
Study 20626055 — intervention group
Group type: EXPERIMENTAL
Intervention: EQT
Number of subjects: 50
Study 17405567 — intervention group
Group type: EXPERIMENTAL
Intervention: New drug-elution stents
Number of subjects: 0
Study 17405567 — intervention group
Group type: COMPARATOR
Intervention: Established methods in interventional cardiology
Number of subjects: 0
Study 15805203 — intervention group
Group type: EXPERIMENTAL
Intervention: 135 degrees four‐hole sliding hip screw (Group A)
Number of subjects: 40
Study 15805203 — intervention group
Group type: COMPARATOR
Intervention: External fixation device with hydroxyapatite‐coated pins (Group B)
Number of subjects: 40
Study 12578811 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (3 microg/min)
Number of subjects: 25
Study 10381908 — intervention group
Group type: EXPERIMENTAL
Intervention: rNV VLPs (250 micrograms) administered orally on days 1 and 21
Number of subjects: 20
Study 10381908 — intervention group
Group type: EXPERIMENTAL
Intervention: rNV VLPs (250 micrograms) administered orally
Number of subjects: 20
Study 8917873 — intervention group
Group type: EXPERIMENTAL
Intervention: DSS (Computerized Decision Support)
Number of subjects: 49
Study 8917873 — intervention group
Group type: COMPARATOR
Intervention: Hospital dosing
Number of subjects: 49
Study 1748137 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocapnic alkalosis (HA)
Number of subjects: 12
Study 1748137 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 12
Study 6123675 — intervention group
Group type: EXPERIMENTAL
Intervention: Metkephamid acetate 70 mg
Number of subjects: 32
Study 6123675 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine hydrochloride 100 mg
Number of subjects: 32
Study 6123675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 28872396 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) group, exercises on the vibrating platform turned on, at a frequency of 50 Hz and amplitude of 4 mm
Number of subjects: 44
Study 28872396 — intervention group
Group type: COMPARATOR
Intervention: Control group, exercise protocol on the vibrating platform turned off
Number of subjects: 44
Study 28694884 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 30
Study 28694884 — intervention group
Group type: EXPERIMENTAL
Intervention: Local steroid injections
Number of subjects: 30
Study 28694884 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (exercise + local steroid injections)
Number of subjects: 30
Study 25565079 — intervention group
Group type: EXPERIMENTAL
Intervention: Box-Cox transformation method for treatment effect estimation
Number of subjects: 0
Study 25565079 — intervention group
Group type: EXPERIMENTAL
Intervention: Box-Cox transformation method
Number of subjects: 0
Study 23321257 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced induction course
Number of subjects: 198
Study 23321257 — intervention group
Group type: COMPARATOR
Intervention: Standard induction course
Number of subjects: 198
Study 23321257 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved 3-log MRD reduction
Number of subjects: 198
Study 20872043 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib malate at a daily dose of 37.5 mg until progression or unacceptable toxicity
Number of subjects: 21
Study 20872043 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib malate at a daily dose of 37.5 mg
Number of subjects: 21
Study 18534911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation in addition to specialist nurse outpatient clinic
Number of subjects: 0
Study 16697808 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel catheter technique (no urethral catheter, handmade cystostomy catheter)
Number of subjects: 146
Study 16697808 — intervention group
Group type: COMPARATOR
Intervention: Traditional procedure (cystostomy and urethral catheter)
Number of subjects: 146
Study 16697808 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel catheter technique
Number of subjects: 146
Study 16697808 — intervention group
Group type: COMPARATOR
Intervention: Traditional procedure
Number of subjects: 146
Study 15514186 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach care (3 telephone calls and 1 home visit within 5 months)
Number of subjects: 536
Study 15514186 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 536
Study 15514186 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach care
Number of subjects: 536
Study 10945486 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan single-agent after 5-FU failure
Number of subjects: 455
Study 9294406 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport (muscle-relaxant doses)
Number of subjects: 295
Study 9294406 — intervention group
Group type: COMPARATOR
Intervention: BOTOX
Number of subjects: 295
Study 9294406 — intervention group
Group type: COMPARATOR
Intervention: Dysport
Number of subjects: 295
Study 9294406 — intervention group
Group type: COMPARATOR
Intervention: Both BOTOX and Dysport
Number of subjects: 295
Study 9294406 — intervention group
Group type: COMPARATOR
Intervention: Untreated volunteers
Number of subjects: 295
Study 9294406 — intervention group
Group type: COMPARATOR
Intervention: Immunized subjects
Number of subjects: 295
Study 8335048 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX + OND
Number of subjects: 36
Study 8335048 — intervention group
Group type: COMPARATOR
Intervention: DEX + ALI
Number of subjects: 36
Study 3595569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment with propranolol
Number of subjects: 0
Study 3595569 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone, suxamethonium, intubation induction sequence
Number of subjects: 0
Study 3595569 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone, alcuronium, intubation induction sequence
Number of subjects: 0
Study 30899941 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin-block appliance treatment in experimental group (21 patients)
Number of subjects: 33
Study 30899941 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 patients)
Number of subjects: 33
Study 27434280 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive exercises
Number of subjects: 45
Study 27434280 — intervention group
Group type: COMPARATOR
Intervention: Isometric quadriceps exercise
Number of subjects: 45
Study 24275841 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (ARB) for 2 years
Number of subjects: 772
Study 24275841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 772
Study 24275841 — intervention group
Group type: COMPARATOR
Intervention: Candesartan and Placebo
Number of subjects: 772
Study 22508710 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation at 4000 IU/d for 1 year
Number of subjects: 52
Study 21182783 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 0.2 μg·kg(‐1)·min(‐1)
Number of subjects: 40
Study 21182783 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine 5 μg·kg(‐1)·min(‐1) (control)
Number of subjects: 40
Study 19102151 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-made spinal expander and bone cement
Number of subjects: 96
Study 19102151 — intervention group
Group type: COMPARATOR
Intervention: PVP
Number of subjects: 96
Study 16621906 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin suppression by GnRH antagonist (cetrorelix) with testosterone and additional administration of the gestogen desogestrel (CTD group)
Number of subjects: 30
Study 16621906 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin suppression by GnRH antagonist (cetrorelix) with testosterone (CT group)
Number of subjects: 30
Study 16621906 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 30
Study 14708413 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol
Number of subjects: 34
Study 14708413 — intervention group
Group type: COMPARATOR
Intervention: Oral calcitriol
Number of subjects: 34
Study 11236258 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ulcerative colitis
Number of subjects: 42
Study 11236258 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ulcerative colitis with rectum-limited inflammatory process
Number of subjects: 42
Study 11236258 — intervention group
Group type: COMPARATOR
Intervention: Healthy persons
Number of subjects: 42
Study 8640161 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and colony-stimulating factors (group I)
Number of subjects: 24
Study 8640161 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF alone (18 patients)
Number of subjects: 24
Study 8640161 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients who did not mobilize CD34+ cells)
Number of subjects: 24
Study 1464047 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal beclomethasone
Number of subjects: 20
Study 1464047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3883265 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 20
Study 3883265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29572630 — intervention group
Group type: COMPARATOR
Intervention: Water (group D)
Number of subjects: 7200
Study 29572630 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronase (group A)
Number of subjects: 7200
Study 29572630 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone (group B)
Number of subjects: 7200
Study 29572630 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronase and Simethicone (group C)
Number of subjects: 7200
Study 29572630 — intervention group
Group type: COMPARATOR
Intervention: Control group (water) vs. Premedication groups (A, B, C)
Number of subjects: 7200
Study 29572630 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis for esophageal lesions
Number of subjects: 7200
Study 29572630 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis for overall lesions
Number of subjects: 7200
Study 27288354 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 1236
Study 27288354 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (O/O)
Number of subjects: 1236
Study 27288354 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1236
Study 27288354 — intervention group
Group type: COMPARATOR
Intervention: placebo/onabotulinumtoxinA (P/O)
Number of subjects: 1236
Study 26715196 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion (30 ml/kg whole blood)
Number of subjects: 3954
Study 26715196 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative transfusion (20 ml/kg)
Number of subjects: 3954
Study 26715196 — intervention group
Group type: COMPARATOR
Intervention: No transfusion (control)
Number of subjects: 3954